PsychoGenics
Business Services · New Jersey, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
215 College Rd 1431, Paramus, New Jersey...Phone Number
(914) 406-8019Website
www.psychogenics.comRevenue
$27 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
2
1
1
About PsychoGenics
PsychoGenics is a preclinical contract research organization (CRO) specializing in drug discovery and development, particularly in central nervous system (CNS) and orphan disorders. The company offers a wide range of preclinical services, including behavioral testing, electrophysiology, and biomarker analysis, utilizing validated disease models to support early-stage drug discovery. Their clients include pharmaceutical and biotechnology companies seeking to reduce attrition rates in clinical development and discover breakthroughs for severe CNS disorders. With over 20 years of experience and a strong focus on customized solutions, PsychoGenics is committed to advancing research in mental illnesses, neurodegenerative disorders, and other therapeutic areas.Explore more
PsychoGenics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is PsychoGenics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if PsychoGenics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at PsychoGenics
Click to see if PsychoGenics had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on PsychoGenics recently announced quarterly report
Product Launch: Get notified when PsychoGenics launches new products
PsychoGenics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once PsychoGenics has new funding data
Check out if PsychoGenics is spiking on competitors!
Recommended Actions
Find VP level buyers at PsychoGenics
Find more new buyers
Compare Similar Companies to PsychoGenics
Compare insights from companies similar to PsychoGenics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
PsychoGenics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
PsychoGenics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about PsychoGenics.
PsychoGenics financials insights
Gather financial insights about PsychoGenics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$1M
PsychoGenics Tech Stack
A closer look at the technologies used by PsychoGenics
Most Recent Scoops
Hiring Plans
PsychoGenics has more open roles in Engineering & Technical than it has had at any time in the past 12 months. Technologies mentioned include: Git, and Python. Areas of expertise include: Software Engineering, AWS Tools, Python (Programming Language), Feature Engineering, Microsoft Azure, System Monitoring, and Data Science.
Hiring Plans
Open Position
Open Position
Event
Product Marketing, Events, Sales, Search, Laboratory Operations, Medical Research, Field /Outside Sales, Clinical Operations, Field Marketing, Healthcare Operations, Operations
Funding
Project
Spending/Investment, Funding
PsychoGenics News & Media
PsychoGenics Awarded an NIH Contract to Test and Identify Novel Therapeutics for Pain
PARAMUS, N.J.--(BUSINESS WIRE)--PsychoGenics Inc. (PsychoGenics) today announced it has been awarded a contract by the National Institutes of Health (NIH) to test and identify novel investigational therapeutics for the treatment of pain. The lack of safe and effective treatments to manage pain is a major public health problem. New treatments that can safely and effectively manage pain are urgently needed. This contract is funded by the National Institute of Neurological Disorders and Stroke (NIPsychoGenics Inc. Awarded $3 Million SBIR Grant to Employ Its AI-Enabled Platforms to Find Treatments for Rare Disorders
PARAMUS, N.J.--(BUSINESS WIRE)--PsychoGenics, a leader in AI-enabled phenotypic drug discovery, has been awarded a Fast Track Small Business Innovation Research (SBIR) grant by NIMH, worth up to $3 million over four years. This grant will support PsychoGenics in utilizing eCube®, its proprietary AI-enabled EEG platform, along with its advanced machine learning tools, to identify novel applications for existing drugs targeting rare diseases. There are approximately 10,000 identified rare diseasePsychoGenics Announces Exclusive Global License for an IND-Ready ENT1 Inhibitor for the Treatment of Neuropsychiatric Disorders
PARAMUS, N.J.--(BUSINESS WIRE)--PGI Drug Discovery LLC (PsychoGenics), a phenotypic drug discovery platform company, announced that it has entered into an exclusive license agreement with Roche to obtain global development, manufacturing, and commercialization rights to RO7117997. RO7117997, is an IND-ready Equilibrative Nucleoside Transporter 1 (ENT1) inhibitor discovered in partnership with Roche using the PsychoGenics’ AI-enabled phenotypic screening platforms. PsychoGenics intends to evaluaPsychoGenics Launches an Updated Corporate Identity and Brand
PARAMUS, N.J.--(BUSINESS WIRE)--PsychoGenics Inc. (“PsychoGenics” or the “Company”), the leading contract research organization (CRO) specializing in central nervous system (CNS) focused preclinical and translational drug discovery services, is proud to unveil its refreshed corporate identity and brand. The change underscores the Company’s deep expertise and customized solutions dedicated to discovering breakthrough CNS treatments for biopharmaceutical companies, disease research foundations an
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding PsychoGenics
Sign Up For FreeTo access detailed company insights
PsychoGenics is a preclinical contract research organization (CRO) specializing in drug discovery and development, particularly in central nervous system (CNS) and orphan disorders. The company offers a wide range of preclinical services, including behavioral testing, electrophysiology, and biomarker analysis, utilizing validated disease models to... Read More
